Logo

Caliper Signs Quality-Control Deal with Artel

Jan 25, 2006

NEW YORK, Jan. 25 (GenomeWeb News) - Caliper Life Sciences and Artel have entered a technology partnership to "strengthen quality assurance for automated liquid delivery systems," Artel announced yesterday.

 

The collaboration involves using Artel's multichannel verification system to test Caliper's Sciclone and RapidPlate automated handlers.

 

The partnership "gives end-users the option to optimize liquid handling equipment using the same methodology as the equipment manufacturer ... allowing for immediate integration and quality assurance," said Artel.

 

Financial details of the alliance were not released.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.